SCHEMBL3957488

SCHEMBL3957488

Cc1ccccc1Nc1nc2ccccc2o1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.67
RAB9A P51151 9/20 0.67
C1R P00736 1/20 0.64
SMN1; SMN2 Q16637 6/20 0.60
PKM P14618 5/20 0.60
MAPT P10636 3/20 0.60
TP53 P04637 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
GAA P10253 2/20 0.60
ALDH1A1 P00352 1/20 0.60
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
LMNA P02545 1/20 0.56
ALOX15 P16050 1/20 0.56
IMPDH2 P12268 1/20 0.50
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GALK1 P51570 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8367944 0.84 NPC1 (0.55) NPC1RAB9AC1RSMN1; SMN2PKM
SCHEMBL6622504 0.82 C1R (0.52) NPC1RAB9AC1RSMN1; SMN2PKM
SCHEMBL15022003 0.82 RAB9A (0.78) NPC1RAB9ASMN1; SMN2PKMMAPT
SCHEMBL1853314 0.80 NPC1 (0.67) NPC1RAB9AC1RSMN1; SMN2PKM
SCHEMBL22285903 0.80 NPC1 (0.67) NPC1RAB9ASMN1; SMN2PKMMAPT
SCHEMBL8567628 0.80 NPC1 (0.67) NPC1RAB9AC1RSMN1; SMN2PKM
SCHEMBL12749633 0.80 NPC1 (0.61) NPC1RAB9ASMN1; SMN2PKMMAPT
SCHEMBL10437491 0.80 RAB9A (0.61) NPC1RAB9AC1RSMN1; SMN2PKM
SCHEMBL14500973 0.79 NPC1 (0.53) NPC1RAB9AC1RSMN1; SMN2PKM
SCHEMBL11385845 0.79 MAPT (0.64) NPC1RAB9AC1RSMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029617-A1 DIARYLAMINE-SUBSTITUTED QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed